For patients with early-stage lung adenocarcinomas, the histological pattern of the tumor predicts the risk of recurrence and might help guide surgical decisions.
For patients with early-stage lung adenocarcinomas, the histological pattern of the tumor predicts the risk of recurrence and might help guide surgical decisions, researchers reported.
In a retrospective study, recurrence was significantly increased among patients who had a tumor resection if 5% or more of the cancer had micropapillary morphology, according to Prasad Adusumilli, MD, of Memorial Sloan-Kettering Cancer Center in New York City, and colleagues.
Knowing what proportion of the tumor has micropapillary morphology could help doctors and patients decide whether to resect the tumor or to remove the lobe, Adusumilli and colleagues reported in the Aug. 20 issue of the Journal of the National Cancer Institute.
The finding is likely to "carry increasing importance" in the next few years as the number of cases of early-stage lung cancer rises as a result of the National Lung Screening Trial, the researchers argued.
Read the full story here: http://bit.ly/1cKwjtc
Source: Med Page Today
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen